Clinical Trials Browser

Unknown × Lymphoma, Non-Hodgkin × Methotrexate × Clear all

NCT04514393 2022-04-07

Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma

Phase 2 Unknown

Lymphoma, Non-Hodgkin